GloCal fellows work in and come from countries around the world. As COVID-19 rages, fellows are living through the choices the countries where their research projects are located have made to control the pandemic.
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization, new UCSF findings published in The New England Journal of Medicine on May 14, 2020.
UCLA professor and team find long-acting injectable cabotegravir is highly effective for the prevention of HIV infection
The HIV Prevention Trials Network (HPTN) announced today results from HPTN 083, a global randomized, controlled, double-blind study showing long-acting injecting cabotegravir lowered HIV incidence among cisgender men and transgender women who have sex with men.
UC Berkeley professor of Public Health/City and Regional Planning at Berkeley Public Health, talks about how communities in urban slums are uniquely vulnerable to COVID-19.
UCLA researcher and Colombian colleagues highlight the importance of good governance of protected areas.
The UCSF effort is being coordinated through the UCSF Department of Medicine’s HEAL (Health, Equity, Action and Leadership) Initiative, a two-year fellowship serving health care workers who are committed to working with disadvantaged rural communities around the world.
As COVID-19 spreads across the globe, a common question is, can infectious diseases be connected to environmental change? Yes, indicates a study published today from the University of California, Davis’ One Health Institute.